https://www.selleckchem.com/products/Fedratinib-SAR302503-TG101348.html The purpose of a bioresorbable scaffold (BRS) is to provide radial support during coronary healing. In this study, coronary artery healing after optical coherence tomography (OCT)- versus angiography-guided magnesium BRS (MBRS) implantation in patients with non-ST-segment-elevation myocardial infarction (NSTEMI) is compared. 75 patients were randomized 11 to OCT- or angiography-guided implantation of a MBRS with protocolled pre- and post-dilation. In the OCT-guided group, prespecified criteria indicating additional intervention were (1) scaffold under-expansion, (2) strut malapposition, (3) edge dissection, and (4) residual stenosis at distal or proximal reference segments. The primary endpoint was OCT-derived healing stage at 6months. At 6months, there was no difference in average healing stage between OCT- and angiography-guided intervention (4.6 [interquartile range (IQR) 4.5-4.7] versus 4.5 [IQR 4.3-4.7]; p=0.54). The MBRSs were completely resolved in 77.0% [IQR 68.5-85.5] versus 76.5% [IQR 67.9-85.T) trial is registered with ClinicalTrials.gov, NCT03016624.Atrial fibrillation (AF) is the most common atrial arrhythmia following coronary artery bypass graft (CABG). Its prevalence is 15-45% and is associated with poor long-term prognosis. Risk factors can be patient-related, intraoperative, and/or postoperative. Therapeutic and preventive strategies have been developed to curtail AF burden. Cardioversion is recommended for unstable or symptomatic patients and rate control if asymptomatic. Anticoagulation is challenging with risk of thromboembolism and bleeding. However, patients should be anticoagulated after cardioversion or if AF persists >48 h and risk factors of stroke exist. A minimum of 4 weeks is recommended but longer duration should be considered in patients at high risk of stroke irrespective of recurrence of AF. To explore the prevalence of poor sleep quality in couples undergoing f